-
1
Advanced genomic techniques are essential for understanding congenital adrenal hyperplasia (CAH) and developing personalized treatment strategies.
-
2
The CYP21A2 locus complexity poses diagnostic challenges, necessitating advanced methods like long-read sequencing for accurate genotyping.
-
3
Genome editing technologies, including CRISPR/Cas9, offer potential for permanent cures for CAH by targeting specific genetic mutations.
-
4
Circulating miRNA profiles in CAH patients provide insights into disease progression and treatment responses, highlighting their potential as biomarkers.
-
5
CAH-X syndrome, linked to TNX haploinsufficiency, illustrates the importance of advanced genomic techniques in identifying genetic conditions associated with CAH.